VitaNova Life Sciences Corp
VNOV· OTC
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-04-30 | $3,025,538 | reported | |
| FY 2025 | 2025-04-30 | $2,662,105 | reported | |
| FY 2024 | 2024-04-30 | $570,694 | reported | |
| FY 2023 | 2023-04-30 | $38,000 | reported | |
| FY 2022 | 2022-04-30 | $120,000 | reported | |
| FY 2021 | 2021-04-30 | $0 | reported | |
| FY 2020 | 2020-04-30 | $0 | reported | |
| FY 2019 | 2019-04-30 | $0 | reported | |
| FY 2018 | 2018-04-30 | $0 revised | reported | |
| FY 2017 | 2017-01-25 | $0 | reported |
VitaNova Life Sciences Corp · CIK 1699709 · Engraved from SEC EDGAR
VitaNova Life Sciences Corp is the 2nd largest of the 5 covered companies the SEC files under this code, by revenue. SIC 5130
Latest filing Sep 14, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
No reported open-market purchases or sales in the last 12 months.
No Form 13F holders on file yet.